Journey Medical DERM
NASDAQ DERM
$6.49 +0.06 (+0.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Journey Medical (DERM) EBITDA (2020)

Updated

Journey Medical (DERM) reported EBITDA of -$32.38 million for FY2021, compared with $9.28 million in FY2020.

Analysis

Journey Medical (DERM) EBITDA (2020) Analysis & Trends

  • According to Business Quant data, EBITDA came in at $9.28 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Journey Medical 176.78 Mn 74.87 Mn 12.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 3.95 Mn
Sep 30, 2020 640,000.00
API Access

Journey Medical EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=DERM&period=max&api_key=YOUR_API_KEY